Clinical trial of ilidar; a new dibenzazepine adrenergic blocking drug, in the treatment of peripheral vascular diseases and miscellaneous complaints.

Authors	H D GREEN, H H DUBOSE
Journal	Circulation (Circulation) Vol. 10 Issue 3 Pg. 374-83 (Sep 1954) ISSN: 0009-7322 [Print] United States
PMID	13190610 (Publication Type: Journal Article)
Chemical References	Adrenergic Agents Dibenzazepines Sympatholytics azapetine dibenzazepine
Topics	Adrenergic Agents Dibenzazepines Peripheral Vascular Diseases (therapy) Sympatholytics (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!